PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 158 filers reported holding PDL BIOPHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $110,000 | +66.7% | 37,863 | +63.9% | 0.01% | +266.7% |
Q4 2018 | $66,000 | -40.0% | 23,100 | -34.4% | 0.00% | -40.0% |
Q2 2016 | $110,000 | -67.6% | 35,200 | -65.6% | 0.01% | -68.8% |
Q1 2016 | $340,000 | +119.4% | 102,200 | +132.3% | 0.02% | +77.8% |
Q4 2015 | $155,000 | +112.3% | 44,000 | +323.1% | 0.01% | +28.6% |
Q1 2015 | $73,000 | -37.6% | 10,400 | -14.0% | 0.01% | -66.7% |
Q2 2014 | $117,000 | +36.0% | 12,100 | +8.0% | 0.02% | +40.0% |
Q2 2013 | $86,000 | – | 11,200 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Argent Trust Co | 41,405 | $102,270 | 0.01% |
Diversified Trust Co | 11,029 | $26,469 | 0.00% |
HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
Ancora Advisors LLC | 4,948 | $0 | 0.00% |
Westside Investment Management, Inc. | 500 | $0 | 0.00% |